Consistent with our previous findings [10], Ser585 phosphorylation of the GM-CSF/IL-3 βc receptor was constitutive in primary AML blasts (Figure 1C) and K562 CML cells (Figure 1D) and was not affected by tyrosine kinase inhibitors (TKIs). This evidence concerns the gene CSF2 and acute myeloid leukemia.